share_log

JP Morgan Reinstates Neutral on Cerevel Therapeutics Hldg, Announces $25 Price Target

Benzinga ·  Nov 20, 2023 07:44

JP Morgan analyst Jessica Fye reinstates Cerevel Therapeutics Hldg (NASDAQ:CERE) with a Neutral and announces $25 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment